Internationally, COPDisprojectedtobethefifthamongtheconditionswithahighburdentosociety. 5 PatientswithCOPDexperienceacuteexacerbationscharacterizedbyachangeinbaselinedyspnea, cough,and/orsputumproductionthatisbeyondnormalday-to-dayvariations,itisacuteinonset,and maywarrantachangeinregularmedication. 6 COPD exacerbationscanrangefromincreasedsymptomsto hospitalizations,respiratoryfailureanddeath.Hospitalizationsforacuteexacerbationsrepresentasignificant part of socioeconomic burden related to COPD. 2, 7 Previousstudieshaveestimatedin-hospital mortalitytorangefrom4%to30%fortheacuteex-acerbationsofCOPD. [8] [9] [10] Hospitalizationforacuteexacerbationsisalsoassociatedwithagreaterriskof mortalityinsubsequentyears,sinceitusuallyoccurs in the advanced phase of disease. Despite the increasinghospitalizationrateforCOPD,availabledata onlong-termsurvivalafterhospitalizationforacute exacerbationsofCOPDislimited.Thelong-termoutcomehavebeenevaluatedinpreviousstudieswith differentend-points,andsomeofthesefollow-up studiesinvestigateddirectlytheprognosisofCOPD patientsrequiringadmissiontotheintensivecareunit (ICU)whichisusuallybelievedtobepoor. [7] [8] [9] [10] [11] [12] [13] [14] [15] One yearmortalityafterhospitalizationforacuteexacerbation of COPD have been reported to range between22%and59%. 6, 9, 11, 12 The2-yearmortalityrates werefoundtobe35.6-49%,andthereportedmortalityratesin3yearswere49-61.2%. 7, 11, 13, 15 Studies onacuteexacerbationofCOPDhavealsoinvestigatedfactorsrelatedtomortality.Somecharacteristicsreportedasriskfactorsareolderage,lowbody massindex(BMI),othercomorbidities,priorfunctionalstatus,cardiacfactors,severityofillness,serum albuminlevel,PaCO2andPaO2. [11] [12] [13] Theimpactof exacerbationsissignificantonthequalityoflifeand prognosisofpatientswithCOPD.COPDprevalence, andriskfactorsmayvaryacrosscountries, 4 andalso healthcaresystemfacilitieshaveconsiderabledifferences.Throughtheimplementationsoftheextended knowledgeontheexacerbationoutcomes,thepotentialpredictorsofmortalityafteranacuteexacerbation of choronic obstructive pulmonary disease (AECOPD)shouldbetakenintoaccountwhenmakinghealth-caredecisionsinthesepatients,andhavingregionaldataonthelong-termoutcomeofCOPD exacerbationswouldbebeneficial.
The purpose of this study was to assess the long-termoutcomesandtodeterminepotentialdeterminantsofsurvivalinagroupofpatientsadmittedforacuteexacerbationofCOPDinTurkey. To do so, we conducted a retrospective cohort studybyobtainingtheinformationfromthedischargereportsandallCOPDpatientshospitalized foracuteexacerbationwereincluded.Thefollowupperiodwasfouryears. In-hospital mortality rate of patients with acuteexacerbationofCOPDhasbeenreportedto bebetween2.5%and30%. 9, 10 Patiletal.reported thelowestin-hospitalmortalityrateof2.5%based onanationwidesampleofpatients. 9 ForthepatientsadmittedtotheICUwithanacuteexacerbation of COPD, mortality was 30% during the hospitalstay. 9 Inpreviousreports,themortality ratehasbeenfoundbetween6.4%and8.3%. 12, 13, 17 In-hospitalmortalityrateofourpatientsrequiring theICUadmission(30.8%)issimilartootherstudies. 10, 15, 18 Themortalityratesfollowinghospitalization foranacuteexacerbationofCOPDwerefoundto beslightlylowercomparedtootherlong-termsurvivalstudies.However,thedifferencebetweenour resultsandtheresultsoftheselong-termsurvival studiesmayberelatedtothepatientpopulation, andthedatacollectionmethod.Thehighestmortalityratesatsubsequentyearsafterhospitaldischargehavebeenreportedforpatientsadmittedto theICUforanacuteexacerbationofCOPD.Seneff etal.foundmortalityas59%oneyearafterhospi-talizationinpatientsaged65yearsorolderadmit-ted to an ICU with an acute exacerbation of COPD. 10 Themortalityratesinone,threeandfive yearswerefoundas42.7%,61.2%and75.9%for patientstreatedintheICUforacuteexacerbation ofCOPDbyAi-Pingetal. 16 Thelargeststudyon survivalafterhospitaladmissionforacuteexacerbationofCOPDwasperformedbyConnorsetal., andtheyreportedthatmortalityratesoneyearand twoyearsafterdischargewere43%and49%,ina cohortof1016patients. 11 However,thehighmortalityratesinfirstyearweretheresultofthepatient population consisted of seriously ill, hypercapnicpatients(PaCO2≥50mmHg).Ourdepartmentisoneofthelargestpneumologywardin the capital of the country, besides its academic function.Therefore,thispatientpopulationisrepresentativeofgeneralpulmonarypractices.With regardtopatientpopulation,thefollowingstudies weresimilartoourstudy,astheyinvestigatedlongtermoutcomesinpatientshospitalizedforanacute exacerbationofCOPDtothepneumologywardsof 20, 24 Inalargecohortofsubjectsfollowedupfor11years,itwas shownthatGOLDclassificationsystempredicted themortality,andriskofdeathincreasedbythe disease severity. 25 In another study, rapid lung functiondeclinewasfoundtobeassociatedwith an increased risk of death in COPD patients. Amongthem,patientswithGOLDstage3and4 diseaseweremorelikelytobeinthemostrapidly decliningquartile. 26 Thepresentstudyshowedthat GOLD 4 patients had an increased risk of death duringthefollow-uptime.Withthisdatacoming fromTurkey,itcanbeemphasizedthatitisimportanttohavepreviouslungfunctionmeasurements to stage the study patients. So we could reliablystageCOPD,andwefoundastrongrelationshipbetweentheGOLDstageandoutcome.
MATERIAL AND METHODS

Patients
In our study, there was no influence of comorbidityonmortalityexpressedbyCharlsoncomorbidityindex,incontrasttoareportbyAlmagro etal.whichfoundthegreatercomorbidityindex (Charlson index) was a significant predictor of mortalityinafollow-upstudyafterhospitalization forCOPD. 7 Thismaybeexplainedbyourlower
Charlsonindexscoresof1.76(ascomparedto2.22 asreportedbyAlmagroetal.),anditshouldberelatedtotheretrospectivedatacollection.
Anotherfindingofourstudywasthatlower BMIwasanindependentpredictoroflong-term mortalityinCOPDpatientsafteranacuteexacerbation.SeveralstudieshaveshownthatlowBMIis a strong predictor of poor long-term survival in COPD. 11, 26, 27 Weight loss is prevalent among patientswithCOPD,20%ofthosewithastable condition,and35%ofpatientswhoarehospital-ized. 29, 30 Bodymassindex<25kg/m²wasdemon-stratedtobeathresholdvaluebelowwhichthe mortalityriskwasincreasedsignificantlybySchols andcolleagues. 27 Inthepresentstudy,thepresenceofcorpulmonalewasdemonstratedtobeassociatedwiththe mortalityinthispopulation.Corpulmonaleisa known factor of poor prognosis in COPD patients. 31, 32 The appropriate treatment of cor pulmonaleandfollow-upofthesepatientsshouldbe performedcarefully,sincethelong-termoutcomes ofpatientswhohavecorpulmonalewillbepoor comparedtoothers.
The need for the ICU admission has been showntobeapredictorofmortalityinCOPDpatientshospitalizedforanacuteexacerbationinthis study. For the ICU patients, the mortality rates werefoundtobe46.1%,61.5%,69.2%,and73%in one,two,threeandfouryears,respectively.The needfortheICUadmissionisaresultofasevere exacerbation,andtheprognosisofthisgroupofpatientsiscommonlybelievedtobepoor. 33 Dataon long-termsurvivalafterhospitaldischargeforthis groupofpatientsislimited.Seneffandcolleagues reportedtheoneyearmortalityas59%,andthey showedthatmortalityhasdoubledinoneyearafter hospitaldischarge. 10 Breenetal.foundthemortalityrateinCOPDpatientstreatedintheICUas64% inthreeyears. 34 Thelongestfollow-upstudysofar reportedamortalityrateof75.9%infiveyears. 15 Accordingtoourresults,patientswhorequireadmission to the ICU have significant in-hospital mortality,andthesurvivorsfromasevereacuteexacerbationhaveanincreasedriskofmortalityin thesubsequentyears.
ThoracicDiseases Şenetal Thelimitationofthisstudywasthatwecould notbeabletoidentifythespecificcauseofdeath, we only reported the overall death rates in this study.Despitethatpoint,ourfollow-upratewas >90%, and the data we used mainly consisted of clinicalandlaboratoryparameterswhichareroutinelyrecordedinpatient'schartinourdepartment. Theresultsofthisstudydemonstrateseveral factors that are useful to predict the long-term mortalityafterhospitalizationforanacuteexacerbation of COPD. Advanced age, severe COPD, lower BMI, the presence of cor pulmonale, and needfortheICUadmissionwereindependentlyassociated with mortality. With this regional data fromTurkey,itwasaimedtoemphasizetheclinical importance of having lung function data for COPDpatientsandusingastandardizedmethod (GOLD)inordertostagethediseasewhichisalso a strong determinant of the long-term outcome afteranacuteexacerbation.
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